Berita Terbaru             -  Good Pharmacovigilance Practice Workshop            -  INFORMASI AWAL UNTUK TENAGA PROFESIONAL KESEHATAN TERKAIT KEAMANAN PRODUK YANG MENGANDUNG BAHAN AKTIF RANITIDIN            -  INFORMASI AWAL UNTUK TENAGA PROFESIONAL KESEHATAN TERKAIT KEAMANAN PRODUK YANG MENGANDUNG BAHAN AKTIF RANITIDIN            -  Tecentriq (Atezolizumab) and New Important Identified Risk of Immune-Related Myositis            -  Actemra® (Tocilizumab) and Risk of Hepatotoxicity

Safety Communication

Safety Alert : Peginterferon Alpha-2a and Facial Palsy Risk

 01 Dec 2016

 Read More

Safety Alert-Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Potensial Risk in The Use of Piperacillin (Alone or in Combination with Tazobactam)

 23 Nov 2016

 Read More

Safety Alert: Zoledronic Acid and Fancony Syndrome Risk

 23 Nov 2016

 Read More

Safety Alert - Adverse Events After Administration of Artesunate injection in five patients in Manokwari, West Papua

 22 Nov 2016

 Read More

Safety Alert: Azithromycin and Risiko Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS)

 08 Sep 2016

 Read More

Recent Post

Polling

How do you think the content and appearance of this website?
  • 39.27%
    Very Interesting
  • 28.31%
    Interesting
  • 13.7%
    Quite Interesting
  • 12.33%
    Not InterestingNot Interesting

© Copyright 2019 BPOM - Indonesia. All Rights Reserved.

How do you think the content and appearance of this website?




logo dsras Email Rapid Alert System

Selamat email anda telah berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia.

 

logo dsras Email Rapid Alert System

Anda ingin berhenti berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia?